Table of Contents
List of Tables
List of Figures
Oxford Immunotec Ltd Company Overview
Oxford Immunotec Ltd Company Snapshot
Oxford Immunotec Ltd Pipeline Products and Ongoing Clinical Trials Overview
Oxford Immunotec Ltd – Pipeline Analysis Overview
Oxford Immunotec Ltd – Key Facts
Oxford Immunotec Ltd – Major Products and Services
Oxford Immunotec Ltd Pipeline Products by Development Stage
Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status
Oxford Immunotec Ltd Pipeline Products Overview
B Cell ELISPOT Assay
B Cell ELISPOT Assay Product Overview
ELISPOT Tumor Assay
ELISPOT Tumor Assay Product Overview
I-O Monitoring Test
I-O Monitoring Test Product Overview
Metabovis Assay – Homocysteine
Metabovis Assay – Homocysteine Product Overview
Risk Stratification System – Kidney Transplantation
Risk Stratification System – Kidney Transplantation Product Overview
SpiroFind
SpiroFind Product Overview
Stratokine
Stratokine Product Overview
T-Cell Select
T-Cell Select Product Overview
T-SPOT Discovery SARS-CoV-2 Test Kit
T-SPOT Discovery SARS-CoV-2 Test Kit Product Overview
T-SPOT Discovery SARS-CoV-2 Test Kit Clinical Trial
T-SPOT.ICA
T-SPOT.ICA Product Overview
UREA And T-SPOT Based Diagnostic Assay – Immunological Disease
UREA And T-SPOT Based Diagnostic Assay – Immunological Disease Product Overview
UREA And T-SPOT Based Diagnostic Assay – Infectious Disease
UREA And T-SPOT Based Diagnostic Assay – Infectious Disease Product Overview
Oxford Immunotec Ltd – Key Competitors
Oxford Immunotec Ltd – Key Employees
Oxford Immunotec Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Oxford Immunotec Ltd, Recent Developments
Aug 04, 2020: Oxford Immunotec reports second quarter 2020 financial results
Feb 20, 2020: Oxford Immunotec announces new data on the utility of T-SPOT.CMV in kidney and stem cell transplant
Jan 23, 2020: Oxford Immunotec announces donation in support of Coronavirus testing efforts to help differentiate Tuberculosis from the new China virus
Nov 05, 2019: Oxford Immunotec reports third quarter 2019 financial results
Aug 06, 2019: Oxford Immunotec reports second quarter 2019 financial results
Jun 24, 2019: Oxford Immunotec appoints Patrick J. Balthrop, Sr. as Chairman
May 17, 2019: Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel
May 09, 2019: Oxford Immunotec reports first quarter 2019 financial results
Mar 28, 2019: Oxford Immunotec announces new initiative to bring the benefit of modern tuberculosis testing to the Russian Federation
Mar 21, 2019: Oxford Immunotec announces Chief Financial Officer transition
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
Oxford Immunotec Ltd Pipeline Products and Ongoing Clinical Trials Overview
Oxford Immunotec Ltd Pipeline Products by Equipment Type
Oxford Immunotec Ltd Pipeline Products by Indication
Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status
Oxford Immunotec Ltd, Key Facts
Oxford Immunotec Ltd, Major Products and Services
Oxford Immunotec Ltd Number of Pipeline Products by Development Stage
Oxford Immunotec Ltd Pipeline Products Summary by Development Stage
Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status
Oxford Immunotec Ltd Ongoing Clinical Trials Summary
B Cell ELISPOT Assay - Product Status
B Cell ELISPOT Assay - Product Description
ELISPOT Tumor Assay - Product Status
ELISPOT Tumor Assay - Product Description
I-O Monitoring Test - Product Status
I-O Monitoring Test - Product Description
Metabovis Assay - Homocysteine - Product Status
Metabovis Assay - Homocysteine - Product Description
Risk Stratification System - Kidney Transplantation - Product Status
Risk Stratification System - Kidney Transplantation - Product Description
SpiroFind - Product Status
SpiroFind - Product Description
Stratokine - Product Status
Stratokine - Product Description
T-Cell Select - Product Status
T-Cell Select - Product Description
T-SPOT Discovery SARS-CoV-2 Test Kit - Product Status
T-SPOT Discovery SARS-CoV-2 Test Kit - Product Description
T-SPOT Discovery SARS-CoV-2 Test Kit - A Phase I/II Randomized, Two Parts, Dose-finding Study to Evaluate the Safety, Tolerability and Immunogenicity of an Inactivated, Adjuvanted Sars-cov-2 Virus Vaccine Candidate (Vla2001), Against Covid-19 in Healthy Subjects
T-SPOT.ICA - Product Status
T-SPOT.ICA - Product Description
UREA And T-SPOT Based Diagnostic Assay - Immunological Disease - Product Status
UREA And T-SPOT Based Diagnostic Assay - Immunological Disease - Product Description
UREA And T-SPOT Based Diagnostic Assay - Infectious Disease - Product Status
UREA And T-SPOT Based Diagnostic Assay - Infectious Disease - Product Description
Oxford Immunotec Ltd, Key Employees
Oxford Immunotec Ltd, Subsidiaries
Glossary